Page 29 - 2023-08-中国全科医学

·926· http: //www.chinagp.net E-mail: zgqkyx@chinagp.net.cn March 2023, Vol.26 No.8

hypertrophic cardiomyopathy［J］. Arrhythm Electrophysiol Rev， 10.1161/CIRCEP.114.002553.
2017，6（2）：63-68. DOI：10.15420/aer.2017.4.2. ［31］WU J T，WANG S L，CHU Y J，et al. CHADS2 and CHA2DS2-
［20］《中国高血压防治指南》修订委员会 . 中国高血压防治指南 VASc scores predict the risk of ischemic stroke outcome in patients
2018 年修订版［J］. 心脑血管病防治，2019，19（1）：1-44. with interatrial block without atrial fibrillation［J］. J Atheroscler
DOI：10.3969/j.issn.1009-816X.2019.01.001. Thromb，2017，24（2）：176-184. DOI：10.5551/jat.34900.
［21］American Diabetes Association. Standards of medical care in ［32］MOK Y，BALLEW S H，BASH L D，et al. International validation
diabetes—2010［J］. Diabetes Care，2010，33（Suppl 1）： of the thrombolysis in myocardial infarction （TIMI） risk score for
S11-61. DOI：10.2337/dc10-S011. secondary prevention in post-MI patients：a collaborative analysis
［22］RAO S J. Regression modeling strategies：with applications to linear of the chronic kidney disease prognosis consortium and the risk
models，logistic regression，and survival analysis［J］. J Am Stat validation scientific committee［J］. J Am Heart Assoc，2018，7（14）：
Assoc，2003，98（461）：257-258. DOI：10.1198/jasa.2003. e008426. DOI：10.1161/JAHA.117.008426.
s263. ［33］QI Y，WANG W Y，ZHANG K，et al. Development and validation
［23］ALBA A C，AGORITSAS T，WALSH M，et al. Discrimination of women acute myocardial infarction in-hospital mortality score
and calibration of clinical prediction models：users' guides to the （WAMI score）［J］. Int J Cardiol，2018，259：31-39. DOI：
medical literature［J］. JAMA，2017，318（14）：1377-1384. 10.1016/j.ijcard.2017.12.010.
DOI：10.1001/jama.2017.12126. ［34］HU W S，LIN C L. CHA2DS2-VASc score for prediction of
［24］VAN CALSTER B，NIEBOER D，VERGOUWE Y，et al. A ischemic stroke in patients with systemic lupus erythematosus
calibration hierarchy for risk models was defined：from Utopia to without atrial fibrillation［J］. Lupus，2018，27（8）：1240-
empirical data［J］. J Clin Epidemiol，2016，74：167-176. 1246. DOI：10.1177/0961203318763535.
DOI：10.1016/j.jclinepi.2015.12.005. ［35］KILIC S，KOCABAS U，CAN L H，et al. Predictive value of
［25］CAMP R L，DOLLED-FILHART M，RIMM D L. X-tile：a new CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed
bio-informatics tool for biomarker assessment and outcome-based reperfusion after thrombolytic therapy in patients with ST-segment
cut-point optimization［J］. Clin Cancer Res，2004，10（21）： elevation myocardial infarction［J］. Cardiol J，2019，26（2）：
7252-7259. DOI：10.1158/1078-0432.CCR-04-0713. 169-175. DOI：10.5603/CJ.a2018.0017.
［26］HE S，CHEN X P，CUI K J，et al. Validity evaluation of recently ［36］VESELKA J. Hypertrophic cardiomyopathy is at increased risk of
published diabetes risk scoring models in a general Chinese thromboembolic events：deficiencies of CHA2DS2-VASC score
population［J］. Diabetes Res Clin Pract，2012，95（2）：291- and how to predict［J］. Can J Cardiol，2019，35（12）：1629-
298. DOI：10.1016/j.diabres.2011.10.039. 1630. DOI：10.1016/j.cjca.2019.07.004.
［27］顾俊，贾锋鹏，封盼攀 . CHADS2 与 CHA2DS2-VASc 评分对非 ［37］ROYSTON P，MOONS K G M，ALTMAN D G，et al. Prognosis
瓣膜病房颤患者左房血栓的风险评估［J］. 南方医科大学学报， and prognostic research：developing a prognostic model［J］.
2014，34（11）：1601-1605. BMJ，2009，338：b604. DOI：10.1136/bmj.b604.
GU J，JIA F P，FENG P P. CHADS2 versus CHA2DS2- VASc ［38］STEYERBERG E W，VERGOUWE Y. Towards better clinical
scoring systems for predicting left atrial Thrombus in patients with prediction models：seven steps for development and an ABCD for
nonvalvular atrial fibrillation［J］. Journal of Southern Medical validation［J］. Eur Heart J，2014，35（29）：1925-1931.
University，2014，34（11）：1601-1605. DOI：10.1093/eurheartj/ehu207.
［28］MELGAARD L，GORST-RASMUSSEN A，LANE D A，et al. ［39］ALTMAN D G，VERGOUWE Y，ROYSTON P，et al. Prognosis
Assessment of the CHA2DS2-VASc score in predicting ischemic and prognostic research：validating a prognostic model［J］.
stroke，thromboembolism，and death in patients with heart failure BMJ，2009，338：b605. DOI：10.1136/bmj.b605.
with and without atrial fibrillation［J］. JAMA，2015，314（10）： ［40］HIPPISLEY-COX J，COUPLAND C，ROBSON J，et al.
1030-1038. DOI：10.1001/jama.2015.10725. Predicting risk of type 2 diabetes in England and Wales：prospective
［29］PAVLOU M，AMBLER G，SEAMAN S R，et al. How to develop a derivation and validation of QDScore［J］. BMJ，2009，338：
more accurate risk prediction model when there are few events［J］. b880. DOI：10.1136/bmj.b880.
BMJ，2015，351：h3868. DOI：10.1136/bmj.h3868. ［41］MOONS K G M，KENGNE A P，GROBBEE D E，et al. Risk
［30］VRIESENDORP P A，SCHINKEL A F L，LIEBREGTS M， prediction models：Ⅱ . External validation，model updating，and
et al. Validation of the 2014 European Society of Cardiology impact assessment［J］. Heart，2012，98（9）：691-698.
guidelines risk prediction model for the primary prevention of DOI：10.1136/heartjnl-2011-301247.
sudden cardiac death in hypertrophic cardiomyopathy［J］. Circ （收稿日期：2022-04-12；修回日期：2022-10-10）
Arrhythm Electrophysiol，2015，8（4）：829-835. DOI： （本文编辑：贾萌萌）